Login or Register
Welcome , Settings |  Logout

Starbucks Promises to Pay Higher UK Taxes

Thursday, 06 Dec 2012 09:07 AM

 

Share:
More . . .
A    A   |
   Email Us   |
   Print   |
Starbucks says it will pay about 10 million pounds ($16 million) in British tax in each of the next two years, after being accused by the country's lawmakers of "immorally" avoiding tax.

UK managing director Kris Engskov said Thursday that the firm had agreed to pay more than required by law, because "our customers clearly expect us to do more."

The company has 700 British outlets, but says it has yet to turn a profit, and has paid just 8.6 million pounds in corporation tax in 14 years.

Starbucks says this is due to a process involving paying royalties to its European headquarters in the Netherlands.

Following criticism from lawmakers and a campaign by protest group U.K. Uncut, Starbucks said this week that it was reviewing its tax approach.

© Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
More . . .
   Email Us   |
   Print   |
Around the Web
Join the Newsmax community.
Register to share your comments with the community. Already a member? Login
Note: Comments from readers do not necessarily reflect the viewpoint of Newsmax Media. While we attempt to review comments, if you see an inappropriate comment you can block it by rolling over the comment, clicking the down arrow and selecting "Flag As Inappropriate."
blog comments powered by Disqus
 
Email:
Country
Zip Code:
 
Top Stories
Around the Web
You May Also Like

Procter & Gamble Brings Back Lafley as CEO

Thursday, 23 May 2013 19:11 PM

Procter & Gamble is bringing back former CEO A.G. Lafley to its top post in a surprise move as the world's largest consu . . .

Apple E-Books Judge: US Can Show Pricing Conspiracy

Thursday, 23 May 2013 18:50 PM

The U.S. has evidence that will show Apple Inc. participated in a conspiracy to raise the prices of electronic books, th . . .

Merck Halts Development of Parkinson's Drug

Thursday, 23 May 2013 18:11 PM

Merck has ended development of preladenant, an experimental drug for Parkinson's disease, after initial data from three  . . .

NEWSMAXWORLD.COM
© Newsmax Media, Inc.
All Rights Reserved